Document Detail

A Preliminary Evaluation of the TOPAS System for the Treatment of Fecal Incontinence in Women.
MedLine Citation:
PMID:  24763157     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVES: The TOPAS AMS pelvic floor repair system is a self-fixating polypropylene mesh intended for use to reinforce soft tissues where weakness exists in the gynecological and gastroenterological anatomy. It is not available commercially in any country. This was a preliminary study conducted to obtain initial clinical experience with the TOPAS system for the treatment of fecal incontinence (FI) in women.
METHODS: This was a prospective study conducted at 5 centers in the United States. Women with FI who failed 1 or more conservative therapies were candidates for the study. Fecal incontinence was assessed with a bowel diary, Cleveland Clinic incontinence scores (CCISs), and Fecal Incontinence Quality of Life (FIQOL) questionnaires, and patients were followed prospectively up to 24 months. Treatment success was defined as a reduction in number of FI episodes of 50% or more compared with baseline.
RESULTS: A total of 29 women (mean age, 60.6 years) were implanted with the TOPAS system. Mean number of FI episodes per 14 days decreased from 6.9 at baseline to 3.5 at 24 months of follow-up, and the reduction was significant for the entire follow-up period compared with baseline (P < 0.001). A total of 55.6% of the subjects reported treatment success. The CCIS and FIQOL scores for all domains were significantly improved during the overall follow-up period compared with baseline (P < 0.001). The most common procedure and/or device-related adverse events were de novo urinary incontinence, including bladder spasms (n = 6), worsening FI (n = 2), and constipation (n = 2). No device-related erosions or extrusions were reported.
CONCLUSIONS: Initial experience of the TOPAS system demonstrated a significant improvement in FI episodes, CCIS and FIQOL scores, and a benign safety profile. These results indicate that the TOPAS system has potential as a new therapeutic option for FI, but it needs to be confirmed in a larger study.
Peter Rosenblatt; Joshua Schumacher; Vincent Lucente; Shane McNevin; Janice Rafferty; Anders Mellgren
Related Documents :
23240877 - The influence of different power settings of nd:yag laser irradiation, bioglass and com...
24630667 - Reproductive performance of lactating dairy cows managed for first service using timed ...
25016577 - Occlusal bite force change after orthodontic treatment with andresen functional appliance.
25034877 - Lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel delivery by combined...
22287367 - High patient satisfaction after secondary rhinoplasty in cleft lip patients.
11369067 - Virtual simulation in patients with breast cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Female pelvic medicine & reconstructive surgery     Volume:  20     ISSN:  2154-4212     ISO Abbreviation:  Female Pelvic Med Reconstr Surg     Publication Date:    2014 May-Jun
Date Detail:
Created Date:  2014-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101528690     Medline TA:  Female Pelvic Med Reconstr Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  155-62     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A group-based yoga therapy intervention for urinary incontinence in women: a pilot randomized trial.
Next Document:  Perioperative anticholinergic medications and risk of catheterization after urogynecologic surgery.